• Xencor settled a dispute with Alexion over U.S. royalties on Ultomiris, securing USD 105 million in two equal payments.
• First USD 52.5 million payment expected in August 2026; second USD 52.5 million due one year after the settlement is executed.
• Alexion will owe no further royalties on U.S. Ultomiris sales; ex-U.S. royalties continue under existing license terms.
• Dispute followed Alexion’s March 2026 position that no additional U.S. royalties were owed, ending future U.S. payments.
• Xencor reinstated its operating runway outlook through 2028 following the settlement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xencor Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607291601BIZWIRE_USPR_____20260729_BW970648) on July 29, 2026, and is solely responsible for the information contained therein.